Dermatitis induced by estrogen and progesterone: dual positive results on the intradermal skin test.
Joon Soo
JS
Park
Ki Hun
KH
Chung
Min Jung
MJ
Lee
Hyun
H
Chung
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D002990:Clobetasol / Q000008:administration & dosage; D003872:Dermatitis / Q000188:drug therapy / Q000209:etiology*; D003990:Dibenzoxepins / Q000008:administration & dosage; D003875:Drug Eruptions / Q000188:drug therapy / Q000209:etiology*; D004359:Drug Therapy, Combination; D004967:Estrogens / Q000009:adverse effects*; D006801:Humans; D007428:Intradermal Tests; D000069605:Olopatadine Hydrochloride; D010793:Phthalazines / Q000008:administration & dosage; D011374:Progesterone / Q000009:adverse effects*; D012882:Skin Tests; D016896:Treatment Outcome; D014221:Triamcinolone / Q000008:administration & dosage
D000893:Anti-Inflammatory Agents; D003990:Dibenzoxepins; D004967:Estrogens; D010793:Phthalazines; D014221:Triamcinolone; D000069605:Olopatadine Hydrochloride; D011374:Progesterone; D002990:Clobetasol; C020976:azelastine